Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-17

Clinical Trial Update: Treatment of Cocaine Dependence With Lisdexamfetamine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing lisdexamfetamine for treating cocaine dependence has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: University of Minnesota | Conditions: Cocaine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2015-09-17